Learn About My Cancer Prevention Work
Public Health • Research • Biotechnology
Public Health
—
Research
—
Biotechnology
Reducing the Burden of Major Disease
Ron has devoted his life to reducing the burden of major diseases, such as cancer, diabetes, and age-associated degenerative disorders. His contributions include ground-breaking scientific studies, educating the next generation of physicians and scientists, promoting public health through advocacy and policy, and launching biopharmaceutical companies to introduce new drugs.
Research & Mentorship
Illuminating fundamental mechanisms of cancer diabetes, obesity, aging & age-associated degenerative disorders.
Biotechnology
Launching numerous biotechnology companies to introduce important drugs for colon, pancreas, and brain cancer.
Public Health Advocacy
Catalyzing community-level coalitions and a unique data platform to reduce disease among underserved youth.
News
Insightful Articles, Interviews, and Presentation Events
2022 Cancer Highlights
The year 2022 marked another major step in the quest to towards making cancer history. Below …
Targeting T cell Checkpoints and Myeloid Suppressors is an Effective Immunotherapy in Pancreas Cancer
Pat Gulhati1and Ronald DePinho2 1Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, …
Opportunity in the Biomedical Roller Coaster
Even in this market meltdown, seasoned biotech innovators with decades of experience know that strong novel …
Biotech Entrepreneurship Series
The road to launching and building a new biotech company is fraught with risk and peppered with complexity and setbacks, both scientific and financial. Advancing groundbreaking science through the rigorous multi-year process of creating and testing a drug requires novel science, top talent, ongoing funding, and acquisition of skills and knowledge that go far beyond the laboratory. As a young academic, following the loss of my father to cancer, I aspired to see my research ideas transform into societal benefit. My subsequent journey in entrepreneurship has provided me with insights into key elements needed for starting a biotech company and converting it into a sustainable enterprise. In this series I will share some lessons I’ve learned.
Leadership Series
Being a successful leader is not an innate skill that you are born with. It has to be learned. My experiences as the Founding Director of the Belfer Center at the Dana Farber Institute and serving as a Professor in the department of Medicine at Harvard helped me grow and learn many important lessons. But they did not prepare me for the challenge of envisioning a new future for a major organization like MD Anderson and moving the entire organization to embrace and enact that vision. Here are just some of my lessons learned, which I hope you will find beneficial.
About Ron DePinho
Physician Scientist Devoted to Reduce Cancer Suffering
Internationally recognized for breakthrough basic and translational research in cancer, aging and age-associated degenerative disorders, Ron advocates to reduce cancer suffering through scientific, government, and humanitarian collaboration.
